Interventional Cardiology and Cardiac Catheterisation : The Essential Guide

Cardiology is becoming an increasingly complex field understood by only a select group of medical specialists. This publication demystifies many difficult topics in interventional cardiology and cardiac catheterisation, commencing with the basics of laboratory instrumentation and technology and progressing to a comprehensive review of both new and established cardiac interventions.

Unlike other publications that are directed mainly towards clinicians, this text is specifically written to assist newcomers such as such as medical trainees, nurses, technicians, scientific staff and other allied health professionals understand the wonders of interventional cardiology, and includes extensive explanations of the techniques of angiography, and new percutaneous.

The comprehensive information presented herein, written by recognised specialists in their respective fields, will no doubt prove of great benefit to clinician and non-medical specialist alike.

John E. Boland is a Science graduate with a background in research and education and has participated as convenor, presenter or invited speaker at numerous local and international scientific and educational meetings. With a particular interest in instrumentation and technology, he has worked as Physiologist/Senior Hospital Scientist for over 30 years as part of the clinical team in the cardiac catheterisation laboratories at St. Vincent’s Hospital, Sydney, and has a conjoint appointment as Senior Lecturer with Central Queensland University. He is an associate member of the Cardiac Society of Australia and New Zealand and the New South Wales Diagnostic and Interventional Cardiology Nurses Group.

David W. M. Muller is director, Cardiac Catheterisation Laboratories at St. Vincent’s Hospital, Sydney, and St Vincent’s Private Hospital, and is associate professor of medicine at the University of NSW. His major interests include optimising the outcomes of complex coronary and peripheral vascular interventions, and the percutaneous management of structural heart disease. He is Principal Investigator for numerous international clinical trials including several first-in-man trials of new devices. He has authored or co-authored multiple peer-reviewed papers, book chapters and abstracts, and has served as an editorial consultant to all the major cardiology journals.